ZP

Zoya Perween

Active Director Director DIN 10958998
DIN 10958998 First appointment Feb 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value •••• Premium profile

About Zoya Perween

Data last updated:

Zoya Perween is a Director at Ajros Pharmaceuticals Private Limited (since 2025). The company operates in Healthcare. Ajros Pharmaceuticals Private Limited reported revenue of ₹3.7 Lakh (FY 2025).

DIN 10958998
Primary Designation Director
Industry Healthcare
First Appointment 21 Feb 2025
Oldest Company Age 5 yrs
Largest company Ajros Pharmaceuticals Private Limited · ₹3.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Feb 20252021₹3.7 Lakh (FY 2025)Active

Board colleagues of Zoya Perween

NameDINCompanyDesignation
Mohammad Seraj Alam10958994Ajros Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ajros Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Zoya Perween

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zoya Perween

Zoya Perween currently holds 1 directorship: Ajros Pharmaceuticals Private Limited (Director, since 21 Feb 2025, revenue ₹3.7 Lakh (FY 2025)).

Zoya Perween was first appointed on 21 Feb 2025 as Director at Ajros Pharmaceuticals Private Limited.

The current boards of Zoya Perween's companies include Mohammad Seraj Alam (Ajros Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available